These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1804685)
1. [The cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs]. Kolchin IuN; Maksiutina NP; Balanda PP; Luĭk AI; Bulakh VN; Moĭbenko AA Farmakol Toksikol; 1991; 54(6):20-3. PubMed ID: 1804685 [TBL] [Abstract][Full Text] [Related]
2. [The effect of the 5-lipoxygenase inhibitor quercetin on the functional and morphologic manifestations of myocardial lesions in ischemia and reperfusion of the heart]. Kolchin IuN; Popovich LF; Grabovskiĭ LA; Luĭk AI; Moĭbenko AA Kardiologiia; 1990 Mar; 30(3):72-5. PubMed ID: 2381127 [TBL] [Abstract][Full Text] [Related]
3. [Morphofunctional analysis of the efficacy of verapamil in experimental ischemia]. Bratus' VV; Sergienko OV; Bezus'ko AG; Shavaran SS Vrach Delo; 1989 Jul; (7):69-72. PubMed ID: 2800508 [TBL] [Abstract][Full Text] [Related]
4. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin]. Vasilevskaia TA; Litvitskiĭ PF Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion. Fiedler VB; Perzborn E; Seuter F Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147 [TBL] [Abstract][Full Text] [Related]
7. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion]. Sochor H Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948 [TBL] [Abstract][Full Text] [Related]
8. Signalling pathways in ischaemic postconditioning. Hausenloy DJ Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104 [TBL] [Abstract][Full Text] [Related]
9. [The anti-ischemic action of a perfluorocarbon emulsion (PFCE) on the canine myocardium]. Ladilov IuV; Islamov BI; Vorob'ev SI; Ivanitskiĭ GR Biull Eksp Biol Med; 1991 Feb; 111(2):139-42. PubMed ID: 1906759 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of verapamil prevention of disorders of cardiac contractile function during ischemia and reperfusion]. Bratus' VV; Bezus'ko AG; Shabaran SS; Filonenko VV Patol Fiziol Eksp Ter; 1989; (5):26-9. PubMed ID: 2616210 [TBL] [Abstract][Full Text] [Related]
11. Further assessment of the protective effect of calmodulin inhibitors against reperfusion injury after acute coronary occlusion in the dog. Gabauer I; Slezak J; Styk J; Ziegelhöffer A Can J Cardiol; 1994; 10(1):125-32. PubMed ID: 8111666 [TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model. Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990 [TBL] [Abstract][Full Text] [Related]
13. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. Hennan JK; Swillo RE; Morgan GA; Keith JC; Schaub RG; Smith RP; Feldman HS; Haugan K; Kantrowitz J; Wang PJ; Abu-Qare A; Butera J; Larsen BD; Crandall DL J Pharmacol Exp Ther; 2006 Apr; 317(1):236-43. PubMed ID: 16344331 [TBL] [Abstract][Full Text] [Related]
14. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910 [TBL] [Abstract][Full Text] [Related]
15. Effects of flecainide on occlusion and reperfusion arrhythmias in dogs. Lederman SN; Wenger TL; Bolster DE; Strauss HC J Cardiovasc Pharmacol; 1989 Apr; 13(4):541-6. PubMed ID: 2470990 [TBL] [Abstract][Full Text] [Related]
16. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Reimer KA; Jennings RB Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220 [TBL] [Abstract][Full Text] [Related]
17. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on ischemia and reperfusion-induced myocardial infarction in rats and dogs. Oh KS; Seo HW; Yi KY; Lee S; Yoo SE; Lee BH Fundam Clin Pharmacol; 2007 Jun; 21(3):255-63. PubMed ID: 17521294 [TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965 [TBL] [Abstract][Full Text] [Related]
19. Effect of antioxidant treatment on the myocardium during reperfusion in dogs. Kónya L; Kékesi V; Nagy SJ; Fehér J Acta Physiol Hung; 1993; 81(3):219-28. PubMed ID: 8197877 [TBL] [Abstract][Full Text] [Related]